ACAD FY 2009 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+302.5% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$45M-710.5% margin

Net Income

-$45M-705.5% margin

EPS (Diluted)

$-1.20

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$38M

Stockholders' Equity

$12M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$2M	+302.5%
Gross Profit	$6M	$2M	+302.5%
Operating Income	-$45M	-$67M	+32.1%
Net Income	-$45M	-$64M	+29.7%